{"pmid":32297671,"title":"Relationships among Lymphocyte Subsets, Cytokines, and the Pulmonary Inflammation Index in Coronavirus (COVID-19) Infected Patients.","text":["Relationships among Lymphocyte Subsets, Cytokines, and the Pulmonary Inflammation Index in Coronavirus (COVID-19) Infected Patients.","We explored the relationships between lymphocyte subsets, cytokines, pulmonary inflammation index (PPI), and disease evolution in patients with COVID-19. A total of 123 patients with COVID-19 were divided into mild and severe groups. Lymphocyte subsets and cytokines were detected on the first day of hospital admission and lung CT results were quantified by PII. Difference analysis and correlation analysis were performed on the two groups. A total of 102 mild and 21 severe patients were included in the analysis. There were significant differences in CD4(+) T, CD8(+) T, IL-6, IL-10 and PII between the two groups. Significant positive correlations between CD4(+) T and CD8(+) T, IL-6 and IL-10 were observed in the mild group (r(2) = 0.694, r(2) = 0.633; P < 0.01). After \"five-in-one\" treatment, all patients were discharged with the exception of the four that died. Higher survival rates were obtained in the mild group and IL-6 within the normal group. CD4(+) T, CD8(+) T, IL-6, IL-10 and PPI can be used as indicators of disease evolution, and PPI can be used as an independent indicator for the disease evolution of COVID-19.","Br J Haematol","Wan, Suxin","Yi, Qingjie","Fan, Shibing","Lv, Jinglong","Zhang, Xianxiang","Guo, Lian","Lang, Chunhui","Xiao, Qing","Xiao, Kaihu","Yi, Zhengjun","Qiang, Mao","Xiang, Jianglin","Zhang, Bangshuo","Chen, Yongping","Gao, Cailiang","32297671"],"abstract":["We explored the relationships between lymphocyte subsets, cytokines, pulmonary inflammation index (PPI), and disease evolution in patients with COVID-19. A total of 123 patients with COVID-19 were divided into mild and severe groups. Lymphocyte subsets and cytokines were detected on the first day of hospital admission and lung CT results were quantified by PII. Difference analysis and correlation analysis were performed on the two groups. A total of 102 mild and 21 severe patients were included in the analysis. There were significant differences in CD4(+) T, CD8(+) T, IL-6, IL-10 and PII between the two groups. Significant positive correlations between CD4(+) T and CD8(+) T, IL-6 and IL-10 were observed in the mild group (r(2) = 0.694, r(2) = 0.633; P < 0.01). After \"five-in-one\" treatment, all patients were discharged with the exception of the four that died. Higher survival rates were obtained in the mild group and IL-6 within the normal group. CD4(+) T, CD8(+) T, IL-6, IL-10 and PPI can be used as indicators of disease evolution, and PPI can be used as an independent indicator for the disease evolution of COVID-19."],"journal":"Br J Haematol","authors":["Wan, Suxin","Yi, Qingjie","Fan, Shibing","Lv, Jinglong","Zhang, Xianxiang","Guo, Lian","Lang, Chunhui","Xiao, Qing","Xiao, Kaihu","Yi, Zhengjun","Qiang, Mao","Xiang, Jianglin","Zhang, Bangshuo","Chen, Yongping","Gao, Cailiang"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32297671","week":"202016|Apr 13 - Apr 19","doi":"10.1111/bjh.16659","keywords":["coronavirus infected disease","cytokines","disease classification","lymphocyte subsets","pulmonary inflammatory index"],"source":"PubMed","weight":0,"locations":["Cytokines","Coronavirus"],"_version_":1664266651295547392,"score":8.233237,"similar":[{"pmid":32227123,"title":"Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia.","text":["Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia.","BACKGROUND: Since December 2019, novel coronavirus (SARS-CoV-2)-infected pneumonia (COVID-19) occurred in Wuhan, and rapidly spread throughout China. We aimed to clarify the characteristics and clinical significance of peripheral lymphocyte subset alteration in COVID-19. METHODS: The levels of peripheral lymphocyte subsets were measured by flow cytometry in 60 hospitalized COVID-19 patients before and after treatment, and their association with clinical characteristics and treatment efficacy was analyzed. RESULTS: Total lymphocytes, CD4+ T cells, CD8+ T cells, B cells and natural killer (NK) cells decreased in COVID-19 patients, and severe cases had a lower level than mild cases. The subsets showed a significant association with the inflammatory status in COVID-19, especially CD8+ T cells and CD4+/CD8+ ratio. After treatment, 37 patients (67%) reached clinical response, with an increase of CD8+ T cells and B cells. No significant change of any subset was detected in non-response cases. In multivariate analysis, post-treatment decrease of CD8+ T cells and B cells and increase of CD4+/CD8+ ratio were indicated as independent predictors for poor efficacy. CONCLUSIONS: Peripheral lymphocyte subset alteration was associated with the clinical characteristics and treatment efficacy of COVID-19. CD8+ T cells tended to be an independent predictor for COVID-19 severity and treatment efficacy.","J Infect Dis","Wang, Fan","Nie, Jiayan","Wang, Haizhou","Zhao, Qiu","Xiong, Yong","Deng, Liping","Song, Shihui","Ma, Zhiyong","Mo, Pingzheng","Zhang, Yongxi","32227123"],"abstract":["BACKGROUND: Since December 2019, novel coronavirus (SARS-CoV-2)-infected pneumonia (COVID-19) occurred in Wuhan, and rapidly spread throughout China. We aimed to clarify the characteristics and clinical significance of peripheral lymphocyte subset alteration in COVID-19. METHODS: The levels of peripheral lymphocyte subsets were measured by flow cytometry in 60 hospitalized COVID-19 patients before and after treatment, and their association with clinical characteristics and treatment efficacy was analyzed. RESULTS: Total lymphocytes, CD4+ T cells, CD8+ T cells, B cells and natural killer (NK) cells decreased in COVID-19 patients, and severe cases had a lower level than mild cases. The subsets showed a significant association with the inflammatory status in COVID-19, especially CD8+ T cells and CD4+/CD8+ ratio. After treatment, 37 patients (67%) reached clinical response, with an increase of CD8+ T cells and B cells. No significant change of any subset was detected in non-response cases. In multivariate analysis, post-treatment decrease of CD8+ T cells and B cells and increase of CD4+/CD8+ ratio were indicated as independent predictors for poor efficacy. CONCLUSIONS: Peripheral lymphocyte subset alteration was associated with the clinical characteristics and treatment efficacy of COVID-19. CD8+ T cells tended to be an independent predictor for COVID-19 severity and treatment efficacy."],"journal":"J Infect Dis","authors":["Wang, Fan","Nie, Jiayan","Wang, Haizhou","Zhao, Qiu","Xiong, Yong","Deng, Liping","Song, Shihui","Ma, Zhiyong","Mo, Pingzheng","Zhang, Yongxi"],"date":"2020-04-01T11:00:00Z","year":2020,"_id":"32227123","week":"202014|Mar 30 - Apr 05","doi":"10.1093/infdis/jiaa150","keywords":["COVID-19","lymphocyte subset","pneumonia"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1663352135252705280,"score":614.3224},{"pmid":32297828,"title":"Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19.","text":["Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19.","The aim of this study was to analyze the correlation between dynamic changes in the nasopharyngeal viral load of patients infected with the new coronavirus causing pneumonia and lymphocyte count disease severity. Cases newly diagnosed with COVID-19 at the First Affiliated Hospital of Nanchang University from January 2020 to February 2020 were analyzed retrospectively. Quantitative real-time polymerase chain reaction was used to determine severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from throat swab sample DeltaCT values; lymphocyte and lymphocyte subset counts, coagulation system factor levels, myocardial injury indexes, and laboratory biochemical indicators were compared between the mild group and the severe group. The correlation between the relative load of nasopharyngeal SARS-CoV-2 RNA and severe disease symptoms was analyzed. Of the 76 patients, 49 were male and 27 were female. The lymphocyte, CD4(+) T lymphocyte, and CD8(+) T lymphocyte counts all differed significantly between the two groups (p < 0.001), as did differences in interleukin (IL)-2R, IL-6, and IL-8 levels (p = 0.022, 0.026, and 0.012, respectively). Moreover, there were significant differences in prothrombin time, D-dimer, and fibrinogen levels between the mild group and the severe group (p = 0.029, 0.006, and <0.001, respectively), and in lactate dehydrogenase and troponin (p < 0.001 and p = 0.007, respectively). SARS-CoV-2 RNA load and lymphocyte count, CD4(+) T lymphocyte count, and CD8(+) T lymphocyte count were linearly negatively correlated (p < 0.001). SARS-CoV-2 RNA load was positively correlated with IL-2R, prothrombin time, lactate dehydrogenase, and hypersensitive troponin T (p = 0.002, p = 0.009, and p < 0.001, respectively). In addition, the time that it took for the nucleic acid test to turn negative was significantly shorter for patients in the mild group than for those in the severe group (Z = -6.713, p < 0.001). In conclusion, relative SARS-CoV-2 RNA load in the nasopharynx is closely related to COVID-19 severity. If the relative RNA load was higher, the lymphocyte count was lower, organ damage was greater, and the time it took for the nucleic acid test to turn negative was longer.","Viral Immunol","Liu, Yang","Liao, Wenjian","Wan, Lagen","Xiang, Tianxing","Zhang, Wei","32297828"],"abstract":["The aim of this study was to analyze the correlation between dynamic changes in the nasopharyngeal viral load of patients infected with the new coronavirus causing pneumonia and lymphocyte count disease severity. Cases newly diagnosed with COVID-19 at the First Affiliated Hospital of Nanchang University from January 2020 to February 2020 were analyzed retrospectively. Quantitative real-time polymerase chain reaction was used to determine severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from throat swab sample DeltaCT values; lymphocyte and lymphocyte subset counts, coagulation system factor levels, myocardial injury indexes, and laboratory biochemical indicators were compared between the mild group and the severe group. The correlation between the relative load of nasopharyngeal SARS-CoV-2 RNA and severe disease symptoms was analyzed. Of the 76 patients, 49 were male and 27 were female. The lymphocyte, CD4(+) T lymphocyte, and CD8(+) T lymphocyte counts all differed significantly between the two groups (p < 0.001), as did differences in interleukin (IL)-2R, IL-6, and IL-8 levels (p = 0.022, 0.026, and 0.012, respectively). Moreover, there were significant differences in prothrombin time, D-dimer, and fibrinogen levels between the mild group and the severe group (p = 0.029, 0.006, and <0.001, respectively), and in lactate dehydrogenase and troponin (p < 0.001 and p = 0.007, respectively). SARS-CoV-2 RNA load and lymphocyte count, CD4(+) T lymphocyte count, and CD8(+) T lymphocyte count were linearly negatively correlated (p < 0.001). SARS-CoV-2 RNA load was positively correlated with IL-2R, prothrombin time, lactate dehydrogenase, and hypersensitive troponin T (p = 0.002, p = 0.009, and p < 0.001, respectively). In addition, the time that it took for the nucleic acid test to turn negative was significantly shorter for patients in the mild group than for those in the severe group (Z = -6.713, p < 0.001). In conclusion, relative SARS-CoV-2 RNA load in the nasopharynx is closely related to COVID-19 severity. If the relative RNA load was higher, the lymphocyte count was lower, organ damage was greater, and the time it took for the nucleic acid test to turn negative was longer."],"journal":"Viral Immunol","authors":["Liu, Yang","Liao, Wenjian","Wan, Lagen","Xiang, Tianxing","Zhang, Wei"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32297828","week":"202016|Apr 13 - Apr 19","doi":"10.1089/vim.2020.0062","keywords":["COVID-19","lymphocyte count","nasopharyngeal virus RNA load","organ damage"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1664266651202224130,"score":599.9897},{"pmid":32217834,"title":"SARS-CoV-2: A Storm is Raging.","text":["SARS-CoV-2: A Storm is Raging.","The pandemic coronavirus infectious disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is rapidly spreading across the globe. In this issue of the JCI, Chen and colleagues compared the clinical and immunologic characteristics between moderate versus severe COVID-19. The authors found that respiratory distress on admission is associated with unfavorable outcomes. Increased cytokine levels (IL-6, IL-10 and TNFalpha), lymphopenia (in CD4+ and CD8+ T cells), and decreased IFNgamma expression in CD4+ T cells are associated with severe COVID-19. Overall, this study characterized the cytokine storm in severe COVID-19 and provides insights into immune therapeutics and vaccine design.","J Clin Invest","Pedersen, Savannah F","Ho, Ya-Chi","32217834"],"abstract":["The pandemic coronavirus infectious disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is rapidly spreading across the globe. In this issue of the JCI, Chen and colleagues compared the clinical and immunologic characteristics between moderate versus severe COVID-19. The authors found that respiratory distress on admission is associated with unfavorable outcomes. Increased cytokine levels (IL-6, IL-10 and TNFalpha), lymphopenia (in CD4+ and CD8+ T cells), and decreased IFNgamma expression in CD4+ T cells are associated with severe COVID-19. Overall, this study characterized the cytokine storm in severe COVID-19 and provides insights into immune therapeutics and vaccine design."],"journal":"J Clin Invest","authors":["Pedersen, Savannah F","Ho, Ya-Chi"],"date":"2020-03-29T11:00:00Z","year":2020,"_id":"32217834","week":"202013|Mar 23 - Mar 29","doi":"10.1172/JCI137647","source":"PubMed","locations":["CD4"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1663352135039844352,"score":482.56598},{"pmid":32026671,"title":"[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].","text":["[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].","Objective: To analyze the clinical characteristics of 2019 novel coronavirus (2019-nCoV) pneumonia and to investigate the correlation between serum inflammatory cytokines and severity of the disease. Methods: 29 patients with 2019-ncov admitted to the isolation ward of Tongji hospital affiliated to Tongji medical college of Huazhong University of Science and Technology in January 2020 were selected as the study subjects. Clinical data were collected and the general information, clinical symptoms, blood test and CT imaging characteristics were analyzed. According to the relevant diagnostic criteria, the patients were divided into three groups: mild (15 cases), severe (9 cases) and critical (5 cases). The expression levels of inflammatory cytokines and other markers in the serum of each group were detected, and the changes of these indicators of the three groups were compared and analyzed, as well as their relationship with the clinical classification of the disease. Results: (1) The main symptoms of 2019-nCoV pneumonia was fever (28/29) with or without respiratory and other systemic symptoms. Two patients died with underlying disease and co-bacterial infection, respectively. (2) The blood test of the patients showed normal or decreased white blood cell count (23/29), decreased lymphocyte count (20/29), increased hypersensitive C reactive protein (hs-CRP) (27/29), and normal procalcitonin. In most patients,serum lactate dehydrogenase (LDH) was significantly increased (20/29), while albumin was decreased(15/29). Alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (Tbil), serum creatinine (Scr) and other items showed no significant changes. (3) CT findings of typical cases were single or multiple patchy ground glass shadows accompanied by septal thickening. When the disease progresses, the lesion increases and the scope expands, and the ground glass shadow coexists with the solid shadow or the stripe shadow. (4) There were statistically significant differences in the expression levels of interleukin-2 receptor (IL-2R) and IL-6 in the serum of the three groups (P<0.05), among which the critical group was higher than the severe group and the severe group was higher than the mildgroup. However, there were no statistically significant differences in serum levels of tumor necrosis factor-alpha (TNF-alpha), IL-1, IL-8, IL-10, hs-CRP, lymphocyte count and LDH among the three groups (P>0.05). Conclusion: The clinical characteristics of 2019-nCoV pneumonia are similar to those of common viral pneumonia. High resolution CT is of great value in the differential diagnosis of this disease. The increased expression of IL-2R and IL-6 in serum is expected to predict the severity of the 2019-nCoV pneumonia and the prognosis of patients.","Zhonghua Jie He He Hu Xi Za Zhi","Chen, L","Liu, H G","Liu, W","Liu, J","Liu, K","Shang, J","Deng, Y","Wei, S","32026671"],"abstract":["Objective: To analyze the clinical characteristics of 2019 novel coronavirus (2019-nCoV) pneumonia and to investigate the correlation between serum inflammatory cytokines and severity of the disease. Methods: 29 patients with 2019-ncov admitted to the isolation ward of Tongji hospital affiliated to Tongji medical college of Huazhong University of Science and Technology in January 2020 were selected as the study subjects. Clinical data were collected and the general information, clinical symptoms, blood test and CT imaging characteristics were analyzed. According to the relevant diagnostic criteria, the patients were divided into three groups: mild (15 cases), severe (9 cases) and critical (5 cases). The expression levels of inflammatory cytokines and other markers in the serum of each group were detected, and the changes of these indicators of the three groups were compared and analyzed, as well as their relationship with the clinical classification of the disease. Results: (1) The main symptoms of 2019-nCoV pneumonia was fever (28/29) with or without respiratory and other systemic symptoms. Two patients died with underlying disease and co-bacterial infection, respectively. (2) The blood test of the patients showed normal or decreased white blood cell count (23/29), decreased lymphocyte count (20/29), increased hypersensitive C reactive protein (hs-CRP) (27/29), and normal procalcitonin. In most patients,serum lactate dehydrogenase (LDH) was significantly increased (20/29), while albumin was decreased(15/29). Alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (Tbil), serum creatinine (Scr) and other items showed no significant changes. (3) CT findings of typical cases were single or multiple patchy ground glass shadows accompanied by septal thickening. When the disease progresses, the lesion increases and the scope expands, and the ground glass shadow coexists with the solid shadow or the stripe shadow. (4) There were statistically significant differences in the expression levels of interleukin-2 receptor (IL-2R) and IL-6 in the serum of the three groups (P<0.05), among which the critical group was higher than the severe group and the severe group was higher than the mildgroup. However, there were no statistically significant differences in serum levels of tumor necrosis factor-alpha (TNF-alpha), IL-1, IL-8, IL-10, hs-CRP, lymphocyte count and LDH among the three groups (P>0.05). Conclusion: The clinical characteristics of 2019-nCoV pneumonia are similar to those of common viral pneumonia. High resolution CT is of great value in the differential diagnosis of this disease. The increased expression of IL-2R and IL-6 in serum is expected to predict the severity of the 2019-nCoV pneumonia and the prognosis of patients."],"journal":"Zhonghua Jie He He Hu Xi Za Zhi","authors":["Chen, L","Liu, H G","Liu, W","Liu, J","Liu, K","Shang, J","Deng, Y","Wei, S"],"date":"2020-02-07T11:00:00Z","year":2020,"_id":"32026671","week":"20206|Feb 03 - Feb 09","doi":"10.3760/cma.j.issn.1001-0939.2020.0005","keywords":["2019 novel coronavirus pneumonia","Clinical features","Disease severity","Inflammatory cytokines"],"source":"PubMed","locations":["Tongji"],"topics":["Diagnosis"],"weight":1,"e_drugs":["Creatinine","Bilirubin"],"_version_":1663352134745194497,"score":453.80478},{"pmid":32217835,"title":"Clinical and immunologic features in severe and moderate Coronavirus Disease 2019.","text":["Clinical and immunologic features in severe and moderate Coronavirus Disease 2019.","BACKGROUND: Since December 2019, an outbreak of Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, and is now becoming a global threat. We aimed to delineate and compare the immunologic features of severe and moderate COVID-19. METHODS: In this retrospective study, the clinical and immunologic characteristics of 21 patients (17 male and 4 female) with COVID-19 were analyzed. These patients were classified as severe (11 cases) and moderate (10 cases) according to the Guidelines released by the National Health Commission of China. RESULTS: The median age of severe and moderate cases was 61.0 and 52.0 years, respectively. Common clinical manifestations included fever, cough and fatigue. Compared to moderate cases, severe cases more frequently had dyspnea, lymphopenia, and hypoalbuminemia, with higher levels of alanine aminotransferase, lactate dehydrogenase, C-reactive protein, ferritin and D-dimer as well as markedly higher levels of IL-2R, IL-6, IL-10, and TNF-alpha. Absolute number of T lymphocytes, CD4+T and CD8+T cells decreased in nearly all the patients, and were markedly lower in severe cases (294.0, 177.5 and 89.0 x 106/L) than moderate cases (640.5, 381.5 and 254.0 x 106/L). The expressions of IFN-gamma by CD4+T cells tended to be lower in severe cases (14.1%) than moderate cases (22.8%). CONCLUSION: The SARS-CoV-2 infection may affect primarily T lymphocytes particularly CD4+T and CD8+ T cells, resulting in decrease in numbers as well as IFN-gamma production. These potential immunological markers may be of importance due to their correlation with disease severity in COVID-19.","J Clin Invest","Chen, Guang","Wu, Di","Guo, Wei","Cao, Yong","Huang, Da","Wang, Hongwu","Wang, Tao","Zhang, Xiaoyun","Chen, Huilong","Yu, Haijing","Zhang, Xiaoping","Zhang, Minxia","Wu, Shiji","Song, Jianxin","Chen, Tao","Han, Meifang","Li, Shusheng","Luo, Xiaoping","Zhao, Jianping","Ning, Qin","32217835"],"abstract":["BACKGROUND: Since December 2019, an outbreak of Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, and is now becoming a global threat. We aimed to delineate and compare the immunologic features of severe and moderate COVID-19. METHODS: In this retrospective study, the clinical and immunologic characteristics of 21 patients (17 male and 4 female) with COVID-19 were analyzed. These patients were classified as severe (11 cases) and moderate (10 cases) according to the Guidelines released by the National Health Commission of China. RESULTS: The median age of severe and moderate cases was 61.0 and 52.0 years, respectively. Common clinical manifestations included fever, cough and fatigue. Compared to moderate cases, severe cases more frequently had dyspnea, lymphopenia, and hypoalbuminemia, with higher levels of alanine aminotransferase, lactate dehydrogenase, C-reactive protein, ferritin and D-dimer as well as markedly higher levels of IL-2R, IL-6, IL-10, and TNF-alpha. Absolute number of T lymphocytes, CD4+T and CD8+T cells decreased in nearly all the patients, and were markedly lower in severe cases (294.0, 177.5 and 89.0 x 106/L) than moderate cases (640.5, 381.5 and 254.0 x 106/L). The expressions of IFN-gamma by CD4+T cells tended to be lower in severe cases (14.1%) than moderate cases (22.8%). CONCLUSION: The SARS-CoV-2 infection may affect primarily T lymphocytes particularly CD4+T and CD8+ T cells, resulting in decrease in numbers as well as IFN-gamma production. These potential immunological markers may be of importance due to their correlation with disease severity in COVID-19."],"journal":"J Clin Invest","authors":["Chen, Guang","Wu, Di","Guo, Wei","Cao, Yong","Huang, Da","Wang, Hongwu","Wang, Tao","Zhang, Xiaoyun","Chen, Huilong","Yu, Haijing","Zhang, Xiaoping","Zhang, Minxia","Wu, Shiji","Song, Jianxin","Chen, Tao","Han, Meifang","Li, Shusheng","Luo, Xiaoping","Zhao, Jianping","Ning, Qin"],"date":"2020-03-29T11:00:00Z","year":2020,"_id":"32217835","week":"202013|Mar 23 - Mar 29","doi":"10.1172/JCI137244","keywords":["Cytokines","Immunology","Infectious disease","Respiration","T cells"],"source":"PubMed","locations":["Guidelines","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1663352135049281536,"score":450.07263}]}